Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 18729173)

1.

Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry.

Brown JR, Malenka DJ, DeVries JT, Robb JF, Jayne JE, Friedman BJ, Hettleman BD, Niles NW, Kaplan AV, Schoolwerth AC, Thompson CA; Dartmouth Dynamic Registry Investigators.

Catheter Cardiovasc Interv. 2008 Sep 1;72(3):347-54. doi: 10.1002/ccd.21619.

PMID:
18729173
2.

Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.

Kini AS, Sarkar K, Rafael OC, Jakkula M, Kaplish D, Lee P, Suleman J, Krishnan P, Kim MC, Sharma SK.

Catheter Cardiovasc Interv. 2009 Jul 1;74(1):49-55. doi: 10.1002/ccd.21946.

PMID:
19288579
3.

The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.

Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.

Catheter Cardiovasc Interv. 2011 Aug 1;78(2):198-201. doi: 10.1002/ccd.22828. Epub 2010 Oct 14.

PMID:
20949583
4.

Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years.

Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Valstar G, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P; Interventional Cardiologists of Thoraxcenter.

Catheter Cardiovasc Interv. 2012 Jul 1;80(1):18-26. doi: 10.1002/ccd.23199. Epub 2012 Apr 17.

PMID:
21735520
5.

Recognizing and reducing the cardiac risk of renal failure.

Vetrovec GW.

Catheter Cardiovasc Interv. 2008 Sep 1;72(3):355-6. doi: 10.1002/ccd.21734. No abstract available.

PMID:
18729175
6.

The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Appleby CE, Ivanov J, Lavi S, Mackie K, Horlick EM, Ing D, Overgaard CB, Seidelin PH, von Harsdorf R, Dzavík V.

Circ Cardiovasc Interv. 2009 Aug;2(4):309-16. doi: 10.1161/CIRCINTERVENTIONS.108.828954. Epub 2009 Jun 30.

7.

Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, Hong MK, Jang Y.

Heart. 2011 Nov;97(21):1753-7. doi: 10.1136/hrt.2010.218677. Epub 2011 May 20.

PMID:
21602521
8.

Serious renal dysfunction after percutaneous coronary interventions can be predicted.

Brown JR, DeVries JT, Piper WD, Robb JF, Hearne MJ, Ver Lee PM, Kellet MA, Watkins MW, Ryan TJ, Silver MT, Ross CS, MacKenzie TA, O'Connor GT, Malenka DJ; Northern New England Cardiovascular Disease Study Group.

Am Heart J. 2008 Feb;155(2):260-6. doi: 10.1016/j.ahj.2007.10.007. Epub 2007 Nov 26.

PMID:
18215595
9.

Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.

Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ; EVENT Registry Investigators.

JACC Cardiovasc Interv. 2009 Nov;2(11):1074-82. doi: 10.1016/j.jcin.2009.09.002.

10.

Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.

Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):352-7. doi: 10.1002/ccd.23394. Epub 2012 May 4.

PMID:
22566286
11.

2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.

Gyöngyösi M, Christ G, Lang I, Kreiner G, Sochor H, Probst P, Neunteufl T, Badr-Eslam R, Winkler S, Nyolczas N, Posa A, Leisch F, Karnik R, Siostrzonek P, Harb S, Heigert M, Zenker G, Benzer W, Bonner G, Kaider A, Glogar D; AUTAX Investigators.

JACC Cardiovasc Interv. 2009 Aug;2(8):718-27. doi: 10.1016/j.jcin.2009.05.019.

12.

Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Kume K, Yasuoka Y, Adachi H, Noda Y, Hattori S, Araki R, Kohama Y, Imanaka T, Matsutera R, Kosugi M, Sasaki T.

Cardiovasc Revasc Med. 2013 Sep-Oct;14(5):253-7. doi: 10.1016/j.carrev.2013.07.009. Epub 2013 Aug 28.

PMID:
23993293
13.

Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?

Yap CH, Yan BP, Akowuah E, Dinh DT, Smith JA, Shardey GC, Tatoulis J, Skillington PD, Newcomb A, Mohajeri M, Pick A, Seevanayagam S, Reid CM.

JACC Cardiovasc Interv. 2009 Aug;2(8):758-64. doi: 10.1016/j.jcin.2009.04.018.

14.

Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience.

Aksoy O, Tuzcu EM, Ellis SG, Whitlow PL, Cam A, Batizy L, Agarwal S, Franco I, Bajzer C, Simpfendorfer C, Raymond R, Nair R, Cho L, Shishehbor MH, Lincoff AM, Kapadia SR.

Catheter Cardiovasc Interv. 2013 Jan 1;81(1):E1-8. doi: 10.1002/ccd.24442. Epub 2012 Nov 8.

PMID:
22508442
15.

A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

Serruys PW, Farooq V, Vranckx P, Girasis C, Brugaletta S, Garcia-Garcia HM, Holmes DR Jr, Kappetein AP, Mack MJ, Feldman T, Morice MC, Ståhle E, James S, Colombo A, Pereda P, Huang J, Morel MA, Van Es GA, Dawkins KD, Mohr FW, Steyerberg EW.

JACC Cardiovasc Interv. 2012 Jun;5(6):606-17. doi: 10.1016/j.jcin.2012.03.016.

16.

Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.

Capodanno D, Ministeri M, Cumbo S, Dalessandro V, Tamburino C.

Catheter Cardiovasc Interv. 2014 May 1;83(6):907-12. doi: 10.1002/ccd.25153. Epub 2013 Aug 31.

PMID:
23934631
17.

Impact of chronic kidney disease on the prognosis of patients undergoing percutaneous coronary interventions using drug-eluting stents.

Kaya E, Cuneo A, Hochadel M, Jünger C, Stepper W, Bramlage P, Kuck KH, Nienaber CA, Senges J, Eckardt L, Tebbe U, Reinecke H.

Clin Res Cardiol. 2011 Dec;100(12):1103-9. doi: 10.1007/s00392-011-0347-7. Epub 2011 Sep 9.

PMID:
21912915
18.

Renal failure after percutaneous coronary intervention is associated with high mortality.

Gupta R, Gurm HS, Bhatt DL, Chew DP, Ellis SG.

Catheter Cardiovasc Interv. 2005 Apr;64(4):442-8.

PMID:
15789398
19.

Differential survival after coronary revascularization procedures among patients with renal insufficiency.

Szczech LA, Reddan DN, Owen WF, Califf R, Racz M, Jones RH, Hannan EL.

Kidney Int. 2001 Jul;60(1):292-9.

20.

Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention.

Kaneko H, Yajima J, Oikawa Y, Tanaka S, Fukamachi D, Suzuki S, Sagara K, Otsuka T, Matsuno S, Funada R, Kano H, Uejima T, Koike A, Nagashima K, Kirigaya H, Sawada H, Aizawa T, Yamashita T.

Heart Vessels. 2014 Mar;29(2):156-64. doi: 10.1007/s00380-013-0339-9. Epub 2013 Apr 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk